Fig. 3From: Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cellsTreatment of HCC cells with tigecycline increases ROS levels. ELISA (A) and flow cytometry (B) based measurement of ROS levels in Huh7 and HepG2 after 48 h of treatment with 10 µM tigecycline. Bar graphs represent the mean ± SD; *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001; ns = no significance compared with the control group (grey bar graphs). RFU relative fluorescent units; Tige, tigecyclineBack to article page